India's Excelris to Market Epistem's POC MDx Test for Tuberculosis
March 08, 2012
India's Excelris to Market Epistem's POC MDx Test for Tuberculosis
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- Epistem Betting BD Distribution Deal for POC TB Test Will Spur Interest in Genedrive Platform
August 9, 2012 / PCR Insider - Dx Focus: Clinical and Regulatory PCR and Nucleic Acid Testing News
October 13, 2011 / PCR Insider - Epistem Prepping Low-Cost, Ultrafast POC MDx Platform for Market
April 7, 2011 / PCR Insider - Epistem Signs $4M Biomarker Deal with Sanofi-Aventis; Preps PoC Platform for Companion Diagnostics
March 23, 2011 / Pharmacogenomics Reporter - UW Researchers Commercializing Nanotip Device for DNA Isolation; Exploring Tech for POC Dx
May 16, 2013 / PCR Insider